Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure Carvedilol or Metoprolol Evaluation Study

Froehlich Hanna; Zhao Jingting; Taeger Tobias; Cebola Rita; Schellberg Dieter; Katus Hugo A.; Grundtvig Morten; Hole Torstein; Atar Dan; Agewall Stefan; Frankenstein Lutz

首页> 外文期刊>Circulation. Heart failure >Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure Carvedilol or Metoprolol Evaluation Study

【24h】

Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure Carvedilol or Metoprolol Evaluation Study

机译：卡维地洛与琥珀酸美托洛尔相比较在稳定型慢性心力衰竭患者中的治疗和预后卡维地洛或美托洛尔的评价研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background -Blockers exert a prognostic benefit in the treatment of chronic heart failure. Their pharmacological properties vary. The only substantial comparative trial to datethe Carvedilol or Metoprolol European Trialhas compared carvedilol with short-acting metoprolol tartrate at different dose equivalents. We therefore addressed the relative efficacy of equal doses of carvedilol and metoprolol succinate on survival in multicenter hospital outpatients with chronic heart failure.

机译：背景-阻断剂在慢性心力衰竭的治疗中具有预后益处。它们的药理特性各不相同。迄今为止唯一的实质性比较试验是卡维地洛或美托洛尔欧洲试验比较了卡维地洛和短效酒石酸美托洛尔酒石酸酯的不同剂量当量。因此，我们探讨了等剂量卡维地洛和琥珀酸美托洛尔对慢性心力衰竭多中心医院门诊患者生存的相对疗效。

著录项

来源
《Circulation. Heart failure》 |2015年第5期|共10页
作者
Froehlich Hanna; Zhao Jingting; Taeger Tobias; Cebola Rita; Schellberg Dieter; Katus Hugo A.; Grundtvig Morten; Hole Torstein; Atar Dan; Agewall Stefan; Frankenstein Lutz;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词
carvedilol; heart failure; metoprolol succinate; mortality; therapy;

机译：卡维地洛;心力衰竭;琥珀酸美托洛尔;死亡率;治疗;

相似文献

外文文献
中文文献
专利

1. Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure Carvedilol or Metoprolol Evaluation Study [J] . Froehlich Hanna, Zhao Jingting, Taeger Tobias, Circulation. Heart failure . 2015,第5期

机译：卡维地洛与琥珀酸美托洛尔相比较在稳定型慢性心力衰竭患者中的治疗和预后卡维地洛或美托洛尔的评价研究
2. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial. [J] . Poole-Wilson PA, Swedberg K, Cleland JG, The Lancet . 2003,第9377期

机译：卡维地洛或美托洛尔欧洲试验（COMET）中卡维地洛和美托洛尔对慢性心力衰竭患者临床结局的比较：随机对照试验。
3. A comparison of the effects of carvedilol and metoprolol on well-being, morbidity, and mortality (the "patient journey") in patients with heart failure: a report from the Carvedilol Or Metoprolol European Trial (COMET). [J] . Cleland JG, Charlesworth A, Lubsen J, Journal of the American College of Cardiology . 2006,第8期

机译：卡维地洛和美托洛尔对心力衰竭患者的幸福感，发病率和死亡率（“患者旅程”）的影响比较：来自卡维地洛或美托洛尔欧洲试验（COMET）的报告。
4. Analysis on the Treatment of Trimetazidine Jointed with Metoprolol in the Coronary Heart Disease with the Heart Failure [C] . Lingdong Meng, Yuntao Cheng International Forum on Bioinformatics and Medical Engineering . 2015

机译：用心力衰竭冠心病中甲状腺腈治疗三嗪治疗的分析
5. Pervasive telemonitoring for patients living with chronic heart failure: A quantitative study of telemedicine acceptance [D] . Liu, Jen-Jyh 2009

机译：慢性心力衰竭患者的普遍远程监控：远程医疗接受度的定量研究
6. Effects of metoprolol and carvedilol on pre‐existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET) [O] . Christian Torp‐Pedersen, Marco Metra, Andrew Charlesworth, 2007

机译：美托洛尔和卡维地洛对慢性心力衰竭患者先前和新发糖尿病的影响：来自卡维地洛或美托洛尔欧洲试验（COMET）的数据
7. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure [O] . Froehlich, H, Torres, L, Taeger, T, 2017

机译：比索洛尔与卡维地洛和琥珀酸美托洛尔治疗慢性心力衰竭患者相比较

Carvedilol Compared With Metoprolol Succinate in the Treatment and Prognosis of Patients With Stable Chronic Heart Failure Carvedilol or Metoprolol Evaluation Study

摘要

著录项

相似文献

相关主题

期刊订阅